Revenue
2022
2023
2024
2025
PROKIDNEY CORP. (PROK)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $893,000 | $76,000 | $0 | $0 | — | — |
| Research & development | $114.1M | $127.7M | $106.7M | $82.1M | $46.3M | $21.0M |
| Operating expenses | $165.9M | $183.8M | $151.5M | $153.0M | $55.1M | $27.0M |
| Operating income | −$165.0M | −$183.7M | −$151.5M | −$153.0M | −$55.1M | −$27.0M |
| EBITDAderived | −$158.4M | −$178.2M | −$147.7M | −$150.0M | −$53.1M | −$26.1M |
| Net income | −$69.0M | −$61.2M | −$35.5M | −$148.1M | −$55.1M | −$26.7M |
| Basic EPSper diluted share | — | — | — | -$0.23 | — | — |
| Diluted EPSper diluted share | — | — | — | -$0.23 | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 13, 2025Form 4 | Pereira Brian JGDirector | SellClass A Common Stock · indirect | 54.3K | $2.37 | $128.8K | 0 |
| Nov 13, 2025Form 4 | Pereira Brian JGDirector | SellClass A Common Stock · indirect | 447.8K | $2.37 | $1.06M | 0 |
| Nov 12, 2025Form 4 | Pereira Brian JGDirector | SellClass A Common Stock · indirect | 27.6K | $2.72 | $75.1K | 54.3K |
| Nov 12, 2025Form 4 | Pereira Brian JGDirector | SellClass A Common Stock · indirect | 227.4K | $2.72 | $618.6K | 447.8K |
| Jul 8, 2025Form 4 · 10b5-1 | Weber Darin J.Chief Regulatory Officer | SellClass A Common Stock | 103.5K | $3.02 | $312.5K | 0 |